Ehi Akhirome

Ehi Akhirome is a Senior Associate at Norwest Venture Partners since June 2022, with experience in biotech and MedTech sectors, involving companies such as Ray Tx, Engrail, Zenas, Rezo, Cytovale, Venostent, Nectero, and BillionToOne. Prior to this role, Ehi Akhirome worked as an Associate at McKinsey & Company from 2018 to 2022. Ehi Akhirome holds both a Doctor of Medicine (MD) and a Doctor of Philosophy (PhD) in Developmental, Regenerative, and Stem Cell Biology from Washington University School of Medicine in St. Louis, obtained between 2012 and 2020, and a bachelor's degree from Emory University, completed in 2012.